Stock Split History
ETFs Holding FOLD »    FOLD Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Amicus Therapeutics is a biotechnology company focused on the discovering, developing, and delivering medicines for diseases. Co.'s Commercial Product and Product Candidates include Galafold® (Migalastat HCl), which is for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data; Enzyme Replacement Therapy for Pompe disease; and Cyclin-dependent kinase-like 5 (CDKL5) Deficiency Disorder, which is a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of several essential proteins for normal brain development. According to our Amicus Therapeutics stock split history records, Amicus Therapeutics has had 0 splits.
Amicus Therapeutics stock split history picture
Amicus Therapeutics (FOLD) has 0 splits in our Amicus Therapeutics stock split history database.

Looking at the Amicus Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amicus Therapeutics shares, starting with a $10,000 purchase of FOLD, presented on a split-history-adjusted basis factoring in the complete Amicus Therapeutics stock split history. Amicus Therapeutics split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/28/2011
End date: 02/25/2021
Start price/share: $6.13
End price/share: $11.92
Dividends collected/share: $0.00
Total return: 94.45%
Average Annual Total Return: 6.88%
Starting investment: $10,000.00
Ending investment: $19,452.01
Years: 10.00
Date Ratio
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
Exela Technologies, Inc. (XELA)
eXp World Holdings, Inc. (EXPI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Amicus Therapeutics
Amicus Therapeutics Insider Buying

Amicus Therapeutics Stock Split History | | Copyright © 2013 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.